Answers are grounded in this paper and cite their sources.
BACKGROUND: Topical application of 5% potassium hydroxide (5% KOH) solution is one of the options available to treat molluscum contagiosum (MC) in children. OBJECTIVES: The study aimed to provide real-world performance and safety data for 5% KOH solution. METHODS: Children aged 2-10 years with MC were treated with topical applications of a 5% KOH solution as monotherapy. The children were followed for 45 days. The primary outcome was the "healing rate on day 45", defined as the percentage of patients with a reduction at day 45 of more than 90% in the number of lesions present at baseline. RESULTS: Of the 109 patients who were included, 106 patients (mean age 6.1 ± 2.3 years, 53.8% boys) were considered for the main analysis. The mean number of MC lesions at baseline was 10.9 ± 9.3 [range 2-60]. The skin lesions had been present for a mean of 10.7 ± 11.6 weeks. All patients received clear explanations about the use of 5% KOH solution. The healing rate on day 45 was 50% [95% CI 40.1-59.9%] in 106 patients. The average percentage reduction in the number of MC lesions at the final visit compared to baseline was 66.6% (minimum -150%, maximum 100%), and 51 patients (48.1%) had no lesions at the final visit, with a mean time to disappearance of 14.7 ± 10.2 days [range 4-50 days; median 10 days]. Two adverse events were considered related to 5% KOH solution: one case of moderate redness and erythema at the application site, and one case of burning sensation on day 1 that led to discontinuation of treatment. CONCLUSIONS: This study supports a favourable benefit-risk ratio for 5% KOH in children for the treatment of MC. Clinical trial registration NCT05680181.
No takes yet. Share an insight, caveat, or question.
Caumes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: